AmerisourceBergen, GNP enlist PrescribeWellness tech
AmerisourceBergen Corp. and its Good Neighbor Pharmacy network will employ technology from PrescribeWellness to deliver and maintain the company’s new Patient Engagement Center.
Pharmacy
CVS Health closes Omnicare acquisition
CVS Health has finalized its $12.9 billion acquisition of Omnicare, a leading provider of pharmacy services to long-term care facilities.
Walgreens, Rite Aid kick off flu shot campaigns
Walgreens and Rite Aid have commenced their annual flu shot campaigns, providing consumers with a range of vaccine options and making it easy for people to get immunized against influenza.
CVS Health launches ScriptSync service
CVS Health is launching a new pharmacy service called ScriptSync, which promises to make it easier and more convenient for patients to take multiple medications as prescribed.
Upsher-Smith gains approval for Namenda generic
Upsher-Smith Laboratories Inc. has received approval from the Food and Drug Administration of an Abbreviated New Drug Application (ANDA) for memantine hydrochloride tablets, a treatment for Alzheimer’s disease, in strengths of 5 mg and 10 mg.
CVS Health: Rx therapy for high cholesterol needs review
The cardiology community should review and reconsider current treatment guidelines for the management of high cholesterol, according to experts at the CVS Health Research Institute.
FLAVORx rolls out iPhone app
FLAVORx aims to help improve adherence to pediatric medications with the launch of its first mobile application for iPhone.
AmerisourceBergen creates nonprofit foundation
AmerisourceBergen Corp. has launched the AmerisourceBergen Foundation, a nonprofit charitable organization that provides grants to health- and pharmaceutical-related causes and educational opportunities.
APhA COO appointed interim executive director of APhA Foundation
Elizabeth Keyes, chief operating officer of the American Pharmacists Association (APhA), has been named as interim executive director of the APhA Foundation with the departure of Mindy Smith.
Aurobindo cleared to market Xanax generic
Aurobindo Pharma Ltd. has gained Food and Drug Administration approval for alprazolam tablets, a medication for anxiety. Aurobindo said its alprazolam product — available in dosages of 0.25 mg, 0.5 mg, 1 mg and 2 mg — is a generic version of Xanax tablets from Pfizer Inc. Part of a group of
Spritam is first FDA-approved 3D printed drug
Aprecia Pharmaceuticals Co. has received Food and Drug Administration approval for Spritam levetiracetam for oral use, an epilepsy treatment made using three-dimensional printing (3DP) technology.
Pfizer to buy U.S. rights for potential MS generic drug
Pfizer Inc. has entered into an agreement with Synthon to acquire the exclusive U.S. commercialization rights for glatiramer acetate, a potential generic version of Teva Pharmaceuticals’ Copaxone for the treatment of relapsing remitting multiple sclerosis (RRMS).
Benzer Pharmacy serves up Rx compliance packaging
Benzer Pharmacy has begun offering free med-pack preparations to customers struggling to remember to take all their medications and keep them organized. The regional drug chain said Monday that the solution employs the Dispill cold-sealed, multidose packaging system from Dispill-USA Inc.
AmerisourceBergen unveils new GNP support network
At its ThoughtSpot 2015 conference, which ended this weekend, AmerisourceBergen Corp. introduced a range of new capabilities for its Pharmacy Services Administration Organization that will bolster support of its Good Neighbor Pharmacy independent pharmacy network.
Hikma to buy Roxane for $2.65 billion
Hikma Pharmaceuticals PLC, a fast growing multinational pharmaceutical group, plans to acquire Roxane Laboratories from Boehringer Ingelheim in a deal valued at $2.65 billion. Hikma said the agreement stands to transform its position in the U.S.
CVS affiliates with Kansas, Pennsylvania health providers
CVS Health has formed new clinical affiliations with Lawrence Memorial Hospital in Kansas and Lehigh Valley Health Network in Pennsylvania.